Damoctocog alfa pegol (Jivi®) – Hemophilia A, ≥ 12 years

1. Characteristics

Start date 01.01.2019
Resolution 20.06.2019
INN Damoctocog alfa pegol
Brand name Jivi®
Company Bayer Vital GmbH
G-BA procedure ID 2019-01-01-D-425
ATC code B02BD39
ICD-10 codes D66Hereditary factor VIII deficiency
DDD 1 TU P
Therapeutic area Hematopoietic diseases
Reason for procedure New INN

Indication (German)

Treatment and prophylaxis of bleeding in previously treated patients ≥ 12 years of age with haemophilia A (congenital factor VIII deficiency).

Subgroup Indication Comparator
Patienten ab einem Alter von 12 Jahren mit Hämophilie A (kongenitalem Faktor-VIII-Mangel) Rekombinante oder aus humanem Plasma gewonnene Blutgerinnungsfaktor-VIII-Präparate

9. Associated procedures

Resolution INN Brand name Indication Additional benefit
Damoctocog alfa pegol Jivi® Hemophilia A, ≥ 12 years


<< List of all resolutions